CRISPRware is a new tool scientists can use to design the best guide RNAs to edit genes in many organisms, without the need for deep bioinformatics expertise. By making gene editing more precise and ...

The partners will use UNP's AI-based macrocycle discovery platform to develop synthetic peptide therapeutics for multiple disease targets.

In the historic period, the growth can be attributed to the increasing prevalence of chronic diseases, heightening demand for targeted therapies, advancements in drug delivery systems and enhanced ...

The research collaboration opens up treatment possibilities for diseases in areas like oncology, cardiometabolic disorders, ...

Argenx wants to get in on the macrocyclic peptide action, penning a deal worth $1.5 billion in biobucks with Californian ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

Researchers reveal how hydration shapes peptide assembly on 2D materials, offering new insights for bioelectronics and ...

Kanazawa University, report in Small, on how short peptides self-assemble linearly on atomically-thick solid surfaces, such ...

Breakthrough in AI-powered drug discovery validates HYFT™-driven peptide design, with broad potential across multiple therapeutic areas The results validate the power of IPA’s LENSai ...

ProteinQure’s lead candidate, PQ203, is a first-in-class peptide-drug conjugate designed to target the sortilin receptor, which is overexpressed in many solid tumors, including TNBC.

Conclusion: dsRNA-selective peptides with high affinity and selectivity were successfully identified using two distinct strategies involving rational design and combinatorial library screening. These ...

This study presents a useful pipeline for de novo design of antimicrobial peptides active both against bacteria and viruses. The method is based on deep learning, using a GAN generator and a ...